GLP1-RAs emerge as biopharma’s most influential platform drug class, reveals GlobalData
GLP-1 receptor agonists (GLP-1RAs) have contributed significantly to the therapeutic landscape, evolving from a primarily diabetes treatment into leading weight-...



















